Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615424 | Journal of Clinical Lipidology | 2016 | 11 Pages |
Abstract
The review of the evidence by the NLA was incomplete. More complete examination of the evidence indicates that apoB is a more accurate marker of cardiovascular risk than non-HDL-C and that the practice of lipidology would be improved by inclusion of apoB along with lipoprotein lipids in routine clinical care.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Allan D. MD, Peter P. MD, PhD, George MD, Curt D. MD, PhD,